share_log

共同药业:北京中伦(武汉)律师事务所关于湖北共同药业股份有限公司2023年限制性股票激励计划首次授予事项的法律意见书

Mutual Pharmaceutical: Legal opinion from Beijing Zhonglun (Wuhan) Law Firm on the first award of Hubei Gongyang Pharmaceutical Co., Ltd.'s 2023 restricted stock incentive plan

SZSI ·  Mar 15, 2023 07:28
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more